Pliant Therapeutics, Inc.PLRXNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P7
Near historical low
vs 5Y Ago
-1x
Contraction
Streak
1 qtr
Consecutive growthDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -22.64% |
| Q3 2025 | -22.87% |
| Q2 2025 | -13.58% |
| Q1 2025 | 6.69% |
| Q4 2024 | 1.87% |
| Q3 2024 | -5.07% |
| Q2 2024 | -1.47% |
| Q1 2024 | 10.05% |
| Q4 2023 | -9.72% |
| Q3 2023 | 5.30% |
| Q2 2023 | 2.97% |
| Q1 2023 | -0.68% |
| Q4 2022 | 61.52% |
| Q3 2022 | 6.35% |
| Q2 2022 | -3.30% |
| Q1 2022 | 9.34% |
| Q4 2021 | 2.28% |
| Q3 2021 | 40.11% |
| Q2 2021 | -16.62% |
| Q1 2021 | 16.69% |
| Q4 2020 | 22.57% |
| Q3 2020 | 51.02% |
| Q2 2020 | -24.21% |
| Q1 2020 | 29.26% |
| Q4 2019 | 20.13% |
| Q3 2019 | -2.27% |
| Q2 2019 | 1.61% |
| Q1 2019 | 0.00% |
| Q1 2018 | 0.00% |